Skip to main content
Top
Published in: Digestive Diseases and Sciences 5/2010

01-05-2010 | Original Article

Determinants of Medical System Delay in the Diagnosis of Colorectal Cancer Within the Veteran Affairs Health System

Authors: Deborah A. Fisher, Leah L. Zullig, Steven C. Grambow, David H. Abbott, Robert S. Sandler, Robert H. Fletcher, Hashem B. El-Serag, Dawn Provenzale

Published in: Digestive Diseases and Sciences | Issue 5/2010

Login to get access

Abstract

Background and Aims

The goals of this study are to evaluate determinants of the time in the medical system until a colorectal cancer diagnosis and to explore characteristics associated with stage at diagnosis.

Methods

We examined medical records and survey data for 468 patients with colorectal cancer at 15 Veterans Affairs medical centers. Patients were classified as screen-detected, bleeding-detected, or other (resulting from the evaluation of another medical concern). Patients who presented emergently with obstruction or perforation were excluded. We used Cox proportional hazards models to determine predictors of time in the medical system until diagnosis. Logistic regression models were used to determine predictors of stage at diagnosis.

Results

We excluded 21 subjects who presented emergently, leaving 447 subjects; the mean age was 67 years and 98% were male, 66% Caucasian, and 43% stage I or II. Diagnosis was by screening for 39%, bleeding symptoms for 27%, and other for 34%. The median times to diagnosis were 73–91 days and were not significantly different by diagnostic category. In the multivariable model for time to diagnosis, older age, having comorbidities, and Atlantic region were associated with a longer time to diagnosis. In the multivariable model for stage-at-diagnosis, only the diagnostic category was associated with stage; the screen-detected category was associated with decreased risk of late-stage cancer.

Conclusions

Our results point to several factors associated with a longer time from the initial clinical event until diagnosis. This increased time in the health care system did not clearly translate into more advanced disease at diagnosis.
Literature
2.
go back to reference Ramos M, Esteva M, Cabeza E, et al. Lack of association between diagnostic and therapeutic delay and stage of colorectal cancer. Eur J Cancer. 2008;44(4):510–521.CrossRefPubMed Ramos M, Esteva M, Cabeza E, et al. Lack of association between diagnostic and therapeutic delay and stage of colorectal cancer. Eur J Cancer. 2008;44(4):510–521.CrossRefPubMed
3.
go back to reference Wattacheril J, Kramer JR, Richardson P, et al. Lagtimes in diagnosis and treatment of colorectal cancer: determinants and association with cancer stage and survival. Aliment Pharmacol Ther. 2008;28(9):1166–1174.CrossRefPubMed Wattacheril J, Kramer JR, Richardson P, et al. Lagtimes in diagnosis and treatment of colorectal cancer: determinants and association with cancer stage and survival. Aliment Pharmacol Ther. 2008;28(9):1166–1174.CrossRefPubMed
4.
go back to reference Korsgaard M, Pedersen L, Sorensen HT, et al. Reported symptoms, diagnostic delay and stage of colorectal cancer: a population-based study in Denmark. Colorectal Disease. 2006;8(8):688–695.CrossRefPubMed Korsgaard M, Pedersen L, Sorensen HT, et al. Reported symptoms, diagnostic delay and stage of colorectal cancer: a population-based study in Denmark. Colorectal Disease. 2006;8(8):688–695.CrossRefPubMed
5.
go back to reference Ayanian JZ, Chrischilles EA, Fletcher RH, et al. Understanding cancer treatment and outcomes: the Cancer Care Outcomes Research and Surveillance Consortium. [erratum appears in J Clin Oncol. 2004 Dec 15;22(24):5026]. J Clin Oncol. 2004;22(15):2992–2996. Ayanian JZ, Chrischilles EA, Fletcher RH, et al. Understanding cancer treatment and outcomes: the Cancer Care Outcomes Research and Surveillance Consortium. [erratum appears in J Clin Oncol. 2004 Dec 15;22(24):5026]. J Clin Oncol. 2004;22(15):2992–2996.
6.
go back to reference Lasson A, Kilander A, Stotzer PO. Diagnostic yield of colonoscopy based on symptoms. Scand J Gastroenterol. 2008;43(3):356–362.CrossRefPubMed Lasson A, Kilander A, Stotzer PO. Diagnostic yield of colonoscopy based on symptoms. Scand J Gastroenterol. 2008;43(3):356–362.CrossRefPubMed
7.
go back to reference Lieberman DA, de Garmo PL, Fleischer DE, et al. Colonic neoplasia in patients with nonspecific GI symptoms. Gastrointest Endosc. 2000;51(6):647–651.CrossRefPubMed Lieberman DA, de Garmo PL, Fleischer DE, et al. Colonic neoplasia in patients with nonspecific GI symptoms. Gastrointest Endosc. 2000;51(6):647–651.CrossRefPubMed
8.
go back to reference Pepin C, Ladabaum U. The yield of lower endoscopy in patients with constipation: survey of a university hospital, a public county hospital, and a Veterans Administration medical center. Gastrointest Endosc. 2002;56(3):325–332.CrossRefPubMed Pepin C, Ladabaum U. The yield of lower endoscopy in patients with constipation: survey of a university hospital, a public county hospital, and a Veterans Administration medical center. Gastrointest Endosc. 2002;56(3):325–332.CrossRefPubMed
9.
go back to reference Piccirillo JF, Tierney RM, Costas I, et al. Prognostic importance of comorbidity in a hospital-based cancer registry. JAMA. 2004;291(20):2441–2447.CrossRefPubMed Piccirillo JF, Tierney RM, Costas I, et al. Prognostic importance of comorbidity in a hospital-based cancer registry. JAMA. 2004;291(20):2441–2447.CrossRefPubMed
11.
go back to reference He YZA, Harrington DP. Imputation in a multiformat and multiwave survey of cancer care. In: Proceedings in Health Policy Statistics. American Statistical Association; 2007. He YZA, Harrington DP. Imputation in a multiformat and multiwave survey of cancer care. In: Proceedings in Health Policy Statistics. American Statistical Association; 2007.
12.
go back to reference Hosmer D, Lemeshow S. Applied Logistic Regression. 2nd ed. New York: Wiley; 2000. Hosmer D, Lemeshow S. Applied Logistic Regression. 2nd ed. New York: Wiley; 2000.
13.
go back to reference Little R, Rubin DB. Statistical Analysis with Missing Data. New York: Wiley; 1986. Little R, Rubin DB. Statistical Analysis with Missing Data. New York: Wiley; 1986.
14.
go back to reference Singh HDK, Petersen LA, Collins C, et al. Missed opportunities to initiate endoscopic evaluation for colorectal cancer diagnosis. Am J Gastroenterol. 2009 online publication. Singh HDK, Petersen LA, Collins C, et al. Missed opportunities to initiate endoscopic evaluation for colorectal cancer diagnosis. Am J Gastroenterol. 2009 online publication.
15.
go back to reference Wennberg JE, Fisher ES, Skinner JS. “Geography and the debate over Medicare reform.” Health Affairs. 2002; W96–114. Wennberg JE, Fisher ES, Skinner JS. “Geography and the debate over Medicare reform.” Health Affairs. 2002; W96–114.
16.
go back to reference Welch WP, Miller ME, Welch HG, Fisher ES, Wennberg JE. Geographic variation in expenditures for physicians’ services in the United States. N Engl J Med. 1993;328:621–627.CrossRefPubMed Welch WP, Miller ME, Welch HG, Fisher ES, Wennberg JE. Geographic variation in expenditures for physicians’ services in the United States. N Engl J Med. 1993;328:621–627.CrossRefPubMed
17.
go back to reference Fisher ES, Wennberg JE, Stukel TA, et al. Associations among hospital capacity, utilization, and mortality of US Medicare beneficiaries, controlling for sociodemographic factors. Health Serv Res. 2000;34:1351–1362.PubMed Fisher ES, Wennberg JE, Stukel TA, et al. Associations among hospital capacity, utilization, and mortality of US Medicare beneficiaries, controlling for sociodemographic factors. Health Serv Res. 2000;34:1351–1362.PubMed
18.
go back to reference Gellad ZF, Almirall D, Provenzale D et al. Time from positive screening fecal occult blood test to colonoscopy and risk of neoplasia. Dig Dis Sci. 2009 in press. Gellad ZF, Almirall D, Provenzale D et al. Time from positive screening fecal occult blood test to colonoscopy and risk of neoplasia. Dig Dis Sci. 2009 in press.
19.
go back to reference Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996;348(9040):1472–1477.CrossRefPubMed Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996;348(9040):1472–1477.CrossRefPubMed
20.
go back to reference Kronborg O, Fenger C, Olsen J, Jorgensen OD, et al. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet. 1996;348(9040):1467–1471.CrossRefPubMed Kronborg O, Fenger C, Olsen J, Jorgensen OD, et al. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet. 1996;348(9040):1467–1471.CrossRefPubMed
21.
go back to reference Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota colon cancer control study. N Engl J Med. 1993;328(19):1365–1371.CrossRefPubMed Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota colon cancer control study. N Engl J Med. 1993;328(19):1365–1371.CrossRefPubMed
Metadata
Title
Determinants of Medical System Delay in the Diagnosis of Colorectal Cancer Within the Veteran Affairs Health System
Authors
Deborah A. Fisher
Leah L. Zullig
Steven C. Grambow
David H. Abbott
Robert S. Sandler
Robert H. Fletcher
Hashem B. El-Serag
Dawn Provenzale
Publication date
01-05-2010
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 5/2010
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-010-1174-9

Other articles of this Issue 5/2010

Digestive Diseases and Sciences 5/2010 Go to the issue